BRVO - BRANCH RETINAL VEIN OCCLUSION
Clinical trials for BRVO - BRANCH RETINAL VEIN OCCLUSION explained in plain language.
Never miss a new study
Get alerted when new BRVO - BRANCH RETINAL VEIN OCCLUSION trials appear
Sign up with your email to follow new studies for BRVO - BRANCH RETINAL VEIN OCCLUSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New eye injection shows promise for blinding swelling
Disease control OngoingThis early-stage study tests a new drug called EYE201, given as three eye injections over 12 weeks, to see if it is safe and can help reduce swelling in the back of the eye. It includes people with three different eye conditions that cause vision loss: branch retinal vein occlusi…
Matched conditions: BRVO - BRANCH RETINAL VEIN OCCLUSION
Phase: PHASE1, PHASE2 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
New syringe design tested for common eye disease treatment
Disease control OngoingThis study tests whether a pre-filled syringe is as safe as the traditional vial when giving the medicine bevacizumab for certain eye diseases. About 120 people with wet age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion will receive inject…
Matched conditions: BRVO - BRANCH RETINAL VEIN OCCLUSION
Phase: PHASE3 • Sponsor: Outlook Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC